U.S. Healthcare Services Stock News

NYSE:AXS
NYSE:AXSInsurance

AXIS Capital (AXS) Stock Still Looks Cheap After A 161% Run

AXIS Capital Holdings has delivered a strong share price run over the past five years, yet the current valuation checks still suggest the stock trades on the cheap side rather than looking fully priced in. AXIS Capital Holdings has returned 160.9% over the past five years, which puts more focus on whether today’s price still offers a margin of safety after such a solid run. For a financial group like AXIS Capital Holdings, investors may see disciplined underwriting and balance sheet strength...
NYSE:AVY
NYSE:AVYPackaging

Has Avery Dennison (AVY) Fallen Far Enough To Look Reasonable?

Avery Dennison stock has retreated over the past few years, yet the valuation checks currently lean on the cheap side. This raises the question of whether the recent weakness has already been more than reflected in the price. The share price is down about 19.2% over five years, which means long-term holders have seen meaningful value erode despite the company remaining on investors' radars. Future cash generation and margin resilience can support a stronger valuation over time. However, any...
NYSE:PRI
NYSE:PRIInsurance

Is Primerica’s (PRI) Budgeting Focus Quietly Reframing Its Core Financial-Guidance Story?

Earlier this week, Primerica released its latest Financial Security Monitor survey, showing how middle-income Americans are reshaping budgets and financial priorities amid rising costs. The findings highlight that, despite pressure on saving and retirement planning, many households are responding by trimming discretionary spending and adhering more strictly to budgets, underscoring demand for practical financial guidance. Now, we’ll examine how this heightened focus on budgeting and...
NYSE:DGX
NYSE:DGXHealthcare

Is Quest Diagnostics (DGX) Stock Still Worth More Than Its Price?

Quest Diagnostics stock has delivered a 79.9% return over the past three years, and the key question now is whether that strong run is still supported by the current valuation. The Discounted Cash Flow (DCF) intrinsic value estimate points to a sizeable gap to the share price, while the broader market multiples suggest the stock is closer to fairly priced. Over the past three years Quest Diagnostics has returned 79.9%, which puts the recent share price firmly in focus for anyone reassessing...
NYSE:FICO
NYSE:FICOSoftware

Fair Isaac (FICO) Stock Stays Reasonable On Cash Flow But Rich On Earnings

Fair Isaac stock has delivered a 128.5% gain over the past 5 years, yet its current checks send mixed signals, with an intrinsic value estimate from a Discounted Cash Flow (DCF) model pointing to upside while traditional earnings based multiples lean expensive and the broader value score sits on the weak side. Over 5 years, Fair Isaac has returned 128.5%, which puts today’s valuation in the spotlight after such a strong longer term run. The recent integration of FICO Score 10T into Optimal...
NYSE:PPL
NYSE:PPLElectric Utilities

The Bull Case For PPL (PPL) Could Change Following Its New Data Center Cost-Shield Pledge

PPL Corporation recently signed the White House's Ratepayer Protection Pledge, underscoring its commitment to keeping power affordable and reliable while ensuring data centers pay for the infrastructure they require. This move highlights how PPL is trying to balance rising data center-driven electricity demand with protections that limit cost shifts onto existing residential and small business customers. We’ll now examine how PPL’s pledge to shield existing customers from data center-related...
NYSE:GIS
NYSE:GISFood

General Mills (GIS) Stock Looks Reasonable Rather Than Clearly Cheap

After several years of weak share price performance, General Mills now trades at levels where its broader valuation checks suggest a mixed picture rather than a clear bargain or clear premium. Over the past 3 years, General Mills shareholders have seen the stock decline 45.6%, which raises the question of whether sentiment has moved ahead of the company’s underlying earnings power. The planned supply chain revamp and targeted US$3b in cost savings by 2030 may support margins and cash...
NYSE:GWRE
NYSE:GWRESoftware

Guidewire (GWRE) Appoints Alexander Vollert To Board As AI Push Takes Shape

Guidewire Software (NYSE:GWRE) has appointed Dr. Alexander Vollert to its Board. Dr. Vollert is known for leading digital transformation and AI initiatives at AXA and Allianz. The appointment is aimed at advancing AI and digital transformation efforts across Guidewire's platform and applications. Guidewire Software enters this governance change with its stock at $131.38 and a mixed return profile. The share price is up 19.8% over the past 30 days and 63.3% over three years, while returns...
NYSE:IR
NYSE:IRMachinery

Is Ingersoll Rand (IR) Fully Priced Following Rising EPS Estimates?

Recent analyst actions around Ingersoll Rand (IR) have focused on the upcoming June quarter earnings report, with higher consensus EPS estimates reflecting increased optimism about the company’s near term financial performance and potential stock reaction. See our latest analysis for Ingersoll Rand. Ingersoll Rand’s recent 1 month share price return of 10.01% contrasts with a 1 year total shareholder return that declined 2.87%, while the 5 year total shareholder return of 75.97% points to a...
NYSE:CRS
NYSE:CRSAerospace & Defense

Carpenter Technology (CRS) Stock Looks Fully Priced After A Very Large Run

Carpenter Technology stock has delivered an extremely strong run over the past few years, yet its valuation checks now lean expensive. This raises questions about how much optimism is already reflected in the current US$601.54 share price. Over the past 5 years, Carpenter Technology has returned about 15x, which puts pressure on the current valuation to be backed by durable fundamentals. Expectations that the company can sustain healthy profitability and cash generation can support the...
NYSE:LMT
NYSE:LMTAerospace & Defense

US Stock Market Today: S&P 500 Futures Slip On Higher Rate And Inflation Concerns

The Morning Bull - US Market Morning Update Friday, Jul, 24 2026 US stock futures are pointing lower this morning, with key contracts on the S&P 500 and Nasdaq down roughly 0.4% as investors focus on rising borrowing costs and stubborn oil driven price pressures. The US 10 year Treasury yield is around 4.65%, which means everything from mortgages to corporate loans is staying expensive. At the same time, US crude inventories climbed by 2.0 million barrels, part of a broader oil story that is...
NYSE:COP
NYSE:COPOil and Gas

Is ConocoPhillips’ (COP) Pre‑Earnings Outperformance Challenging the Cautious Zacks Rank #4 Narrative?

In recent sessions, ConocoPhillips drew heightened investor attention as the stock outperformed major indices ahead of its August 6, 2026 earnings report, which occurred earlier this month. Despite expectations for meaningful earnings growth at that time, the stock held a Zacks Rank of #4 (Sell), underscoring a cautious stance from at least one analyst framework. We’ll now consider how this anticipation around the August earnings release, against a cautious analyst rating backdrop, might...
NYSE:WMK
NYSE:WMKConsumer Retailing

Weis Markets (WMK) Following Its Dividend Update Is The Stock Fully Valued

Weis Markets (WMK) shares are in focus after the company’s board declared a quarterly dividend of $0.34 per share, payable on August 10, 2026, to shareholders of record on July 27. See our latest analysis for Weis Markets. At a share price of $74.74, Weis Markets has cooled off in the short term, with the 1 day, 7 day and 30 day share price returns all down. However, the 90 day share price return of 8.76% and 5 year total shareholder return of 51.73% indicate that longer term momentum has...
NYSE:GM
NYSE:GMAuto

GM’s Buybacks, Guidance Hike, and Software Push Could Be A Game Changer For General Motors (GM)

In July 2026, General Motors reported second-quarter revenue of US$48,026 million and net income of US$1,305 million, raised its full-year earnings guidance, completed a US$14.47 billion share repurchase program covering 24.61% of its stock, affirmed a US$0.18 quarterly dividend, and filed a US$2.05 billion ESOP-related shelf registration. Beyond vehicle sales, GM highlighted accelerating growth in its software and subscription business, underscoring a shift toward higher-margin, recurring...
NasdaqGS:ON
NasdaqGS:ONSemiconductor

ON Semiconductor (ON) Stock Trades At A Premium To Fair Value

ON Semiconductor stock has delivered a 133.4% return over the past five years, yet its current valuation checks suggest the shares may be trading at a premium to an estimate of intrinsic value based on a Discounted Cash Flow (DCF) model and earnings multiples that both lean overvalued. A 133.4% return over five years highlights that ON Semiconductor has already rewarded long term holders, which can lower the margin of safety for new investors if expectations are high. Expectations for ON...
NYSE:CLF
NYSE:CLFMetals and Mining

Cleveland Cliffs (CLF) Could Be 28% Below Fair Value On Improving Q2 Results

Why Cleveland-Cliffs Stock Is Back in Focus After Q2 Results Cleveland-Cliffs (CLF) has drawn fresh attention after reporting second quarter and half year 2026 results, showing higher sales and a much smaller net loss compared with the same periods last year. See our latest analysis for Cleveland-Cliffs. The latest earnings update appears to have shifted sentiment, with Cleveland-Cliffs' share price jumping 15.98% on the day and 15.01% over the past week. However, the year to date share price...
NasdaqGS:TSCO
NasdaqGS:TSCOSpecialty Retail

Tractor Supply (TSCO) Cuts Outlook And Closes 75 Petsense Stores

Tractor Supply (NasdaqGS:TSCO) reported Q2 results that fell short of expectations and reduced its full year outlook. The company plans to close about 75 underperforming Petsense stores as part of a broader review of its pet specialty footprint. Management also outlined a slower pace of new store openings, citing ongoing adverse weather, weaker rural demand, and rising competition. Tractor Supply focuses on farm, ranch, and rural lifestyle customers, a segment that has faced pressure from...
NYSE:MCK
NYSE:MCKHealthcare

How Investors May Respond To McKesson (MCK) Dividend Hike And Portfolio Reshaping Strategy

McKesson Corporation recently approved a quarterly dividend of US$0.94 per share, payable on October 1, 2026, to shareholders of record as of the September 1, 2026 ex-dividend date, marking its tenth consecutive year of dividend increases. This 15% dividend raise, alongside ongoing portfolio streamlining and oncology expansion, underlines management’s focus on steady cash returns while reshaping the business mix. We’ll now examine how McKesson’s higher dividend and portfolio reshaping may...
NasdaqCM:SBET
NasdaqCM:SBETHospitality

Sharplink (SBET) Rebounds As Valuation Questions Persist

Sharplink (SBET) is on investors’ radar after recent trading placed its market value around US$1.23b, with the stock closing at US$6.00 and showing mixed return patterns across different timeframes. See our latest analysis for Sharplink. Recent trading in Sharplink highlights a sharp contrast between shorter term share price momentum and longer term outcomes. The 30 day share price return is up 20.85%, while the year to date share price return is down 38.08% and the 1 year total shareholder...
NYSE:ALSN
NYSE:ALSNMachinery

Allison Transmission (ALSN) Stock Could Be 49% Undervalued After A $250M Defense Order

Allison Transmission Holdings has delivered a 225.8% total return over the past five years, yet its current share price still screens as cheap against an intrinsic value estimate from a Discounted Cash Flow (DCF) model and supporting market multiples. Recent defense contract wins add fresh cash flow expectations into the mix, raising the question of whether the market is still underpricing that future stream. A 225.8% return over five years points to a stock that has already rewarded long...
NasdaqGS:BBIO
NasdaqGS:BBIOBiotechs

Is FDA’s Encaleret NDA Acceptance Redefining the Investment Case For BridgeBio Pharma (BBIO)?

BridgeBio Pharma recently announced that the FDA has accepted for filing its New Drug Application for encaleret to treat autosomal dominant hypocalcemia type 1, assigning a PDUFA target action date of May 8, 2027, and indicating no advisory committee meeting is currently planned. If approved, encaleret would be the first therapy specifically indicated for ADH1, targeting the underlying genetic cause and potentially obviating the need for chronic calcium and vitamin D supplementation in this...
NasdaqGS:SBGI
NasdaqGS:SBGIMedia

Sinclair (SBGI) Faces A Pullback Following Streaming Narrative That Still Points To Undervaluation

Sinclair (SBGI) is back on investors’ radar after recent trading left the stock down 4% over the past month and 15% over the past 3 months, sharpening focus on its media-focused business model. See our latest analysis for Sinclair. At a share price of $13.37, Sinclair’s recent 7 day share price return of down 6.8% and year to date share price return of down 12.2% contrast with a 3 year total shareholder return of about 24%. This suggests recent momentum has faded even though longer term...
NYSE:NKE
NYSE:NKELuxury

Nike (NKE) Is Resetting China Online Sales Around Its Own Flagship Stores

Nike (NYSE:NKE) plans to shift all online sales in China to Nike-operated flagship stores on major platforms from 2027. The company intends to end online distribution through thousands of wholesale partners in the Greater China region. This reset focuses on tighter control of pricing, product selection, and brand presentation across Chinese ecommerce channels. Nike is a global sportswear company with a long-standing focus on direct-to-consumer channels, and China is one of its most...
NYSEAM:PRK
NYSEAM:PRKBanks

Park National (PRK) Draws Valuation Focus, Is The Stock Still Cheap?

Recent returns put Park National in focus Park National (PRK) is drawing investor attention after a run that includes a year to date total return of 19.8% and a past 3 months total return of 7.6%. These returns are prompting fresh questions about valuation and risk. See our latest analysis for Park National. Recent trading has cooled slightly, with the share price down 3.8% over the past week but still showing a 7.6% 90 day share price return and a 91.8% total shareholder return over five...